Breast Cancer Action advocates for more effective and less toxic breast cancer treatments by shifting the balance of power in the FDA’s drug approval process away from the powerful pharmaceutical industry.
Join us for the second of BCAction’s free monthly webinar series to find out how to help make sure that the FDA’s standards put public health before private profit. We will focus on how the competing interests of pharmaceutical companies and regulatory governmental bodies can fail to deliver safe and effective drugs that patients need. If you sign up, you will learn about power players at the FDA, the origins of the accelerated approval process, and more.
Jane Zones, Medical Sociologist and Former BCAction Board Member